Biovest International appeared to be the Corporate Investor, which was created in 1981. The venture was found in North America in United States. The main department of described Corporate Investor is located in the Tampa.
Among the most successful fund investment fields, there are Biotechnology, Medical Device. For fund there is no match between the country of its foundation and the country of its the most frequent investments - Belgium. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. Among the various public portfolio startups of the fund, we may underline AgroSavfe, MDxHealth
The current fund was established by Christopher Kyriakides.
The fund is constantly included in less than 2 investment rounds annually. The higher amount of exits for fund were in 2006. The top activity for fund was in 2019. The common things for fund are deals in the range of 10 - 50 millions dollars. Opposing the other organizations, this Biovest International works on 4 percentage points more the average amount of lead investments.
The typical case for the fund is to invest in rounds with 7-8 participants. Despite the Biovest International, startups are often financed by VIB, Qbic, PMV. The meaningful sponsors for the fund in investment in the same round are VIB, Sofinnova Partners, PMV. In the next rounds fund is usually obtained by VIB, Sofinnova Partners, Qbic Fund.
Related Funds
Fund Name | Location |
Aglaia Family Office | Central, Central Region, Singapore |
Closed Loop Partners | New City, New York, United States |
FIL Capital Management | - |
Jiangyin Ruixin | China, Jiangsu, Jiangyin |
MidOcean Partners | New York, New York, United States |
Shubert Organization | New York, New York, United States |
STAK Bropelli | - |
Valiance Solutions | New York, New York, United States |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Biotalys | $41M | 30 Jul 2019 | Ghent, East Flanders, Belgium | ||
Biotalys | $11M | 09 Mar 2017 | Belgium, East Flanders |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Biotalys | $41M | 30 Jul 2019 | Ghent, East Flanders, Belgium | ||
Biotalys | $11M | 09 Mar 2017 | Belgium, East Flanders |